{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:10Z","timestamp":1790716990794,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-01330"],"award-info":[{"award-number":["2017-01330"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type I interferons, particularly interferon-alpha (IFN-\u03b1), play a vital role in the host's anti-viral defenses by interfering with viral replication. However, the virus rapidly evolves to exploit the IFN-\u03b1 response for its replication, spread, and pathogenic function. In this study, we attempted to determine IFN-\u03b1 susceptibility and productivity of infectious transmitted\/founder (TF) (n\u2009=\u20098) and non-transmitted (NT) viruses (n\u2009=\u20098) derived from HIV-1 infected infants. Independent experiments were carried out to determine IFN-\u03b1 resistance, replication fitness, and viral productivity in CD4<jats:sup>+<\/jats:sup>T cells over a short period.<jats:italic>In vitro<\/jats:italic>studies showed that TF viruses were resistant to IFN-\u03b1 during the very near moment of transmission, but in the subsequent time points, they became susceptible to IFN-\u03b1. We did not observe much difference in replicative fitness of the TF viruses in cultures treated with and without IFN-\u03b1, but the difference was significant in the case of NT viruses obtained from the same individual. Despite increased susceptibility to IFN-\u03b1, NT viruses produced more viral particles than TF viruses. Similar results were also obtained in cultures treated with maraviroc (MVC). The study identified unique characteristics of TF viruses thus prompting further investigation into virus-host interaction occurring during the early stages of HIV infection.<\/jats:p>","DOI":"10.1038\/s41598-020-59596-x","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T11:07:02Z","timestamp":1581937622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7880-9497","authenticated-orcid":false,"given":"Manickam","family":"Ashokkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aanand","family":"Sonawane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Sperk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth P.","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0844-3338","authenticated-orcid":false,"given":"Ujjwal","family":"Neogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke Elizabeth","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"key":"59596_CR1","doi-asserted-by":"publisher","unstructured":"Stefic, K. et al. Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time. Journal of virology, https:\/\/doi.org\/10.1128\/jvi.01492-18 (2018).","DOI":"10.1128\/jvi.01492-18"},{"key":"59596_CR2","doi-asserted-by":"publisher","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","volume":"2","author":"EJ Arts","year":"2012","unstructured":"Arts, E. J. & Hazuda, D. J. HIV-1 antiretroviral drug therapy. Cold Spring Harbor perspectives in medicine 2, a007161\u2013a007161, https:\/\/doi.org\/10.1101\/cshperspect.a007161 (2012).","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"59596_CR3","doi-asserted-by":"publisher","first-page":"e1004625","DOI":"10.1371\/journal.pcbi.1004625","volume":"11","author":"TT Immonen","year":"2015","unstructured":"Immonen, T. T., Conway, J. M., Romero-Severson, E. O., Perelson, A. S. & Leitner, T. Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population. PLoS computational biology 11, e1004625\u2013e1004625, https:\/\/doi.org\/10.1371\/journal.pcbi.1004625 (2015).","journal-title":"PLoS computational biology"},{"key":"59596_CR4","doi-asserted-by":"publisher","first-page":"e1006510","DOI":"10.1371\/journal.ppat.1006510","volume":"13","author":"GH Kijak","year":"2017","unstructured":"Kijak, G. H. et al. Rare HIV-1 transmitted\/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection. PLoS pathogens 13, e1006510, https:\/\/doi.org\/10.1371\/journal.ppat.1006510 (2017).","journal-title":"PLoS pathogens"},{"issue":"Suppl 1","key":"59596_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-s1-s6","volume":"9","author":"JC Grivel","year":"2011","unstructured":"Grivel, J. C., Shattock, R. J. & Margolis, L. B. Selective transmission of R5 HIV-1 variants: where is the gatekeeper. Journal of translational medicine 9(Suppl 1), S6, https:\/\/doi.org\/10.1186\/1479-5876-9-s1-s6 (2011).","journal-title":"Journal of translational medicine"},{"key":"59596_CR6","doi-asserted-by":"publisher","first-page":"e10770","DOI":"10.2196\/10770","volume":"4","author":"RM Selik","year":"2018","unstructured":"Selik, R. M. & Linley, L. Viral Loads Within 6 Weeks After Diagnosis of HIV Infection in Early and Later Stages: Observational Study Using National Surveillance. Data. JMIR public health and surveillance 4, e10770, https:\/\/doi.org\/10.2196\/10770 (2018).","journal-title":"Data. JMIR public health and surveillance"},{"key":"59596_CR7","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1073\/pnas.1304288110","volume":"110","author":"NF Parrish","year":"2013","unstructured":"Parrish, N. F. et al. Phenotypic properties of transmitted founder HIV-1. Proceedings of the National Academy of Sciences of the United States of America 110, 6626\u20136633, https:\/\/doi.org\/10.1073\/pnas.1304288110 (2013).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"59596_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-146","volume":"10","author":"AE Fenton-May","year":"2013","unstructured":"Fenton-May, A. E. et al. Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology 10, 146, https:\/\/doi.org\/10.1186\/1742-4690-10-146 (2013).","journal-title":"Retrovirology"},{"key":"59596_CR9","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1128\/jvi.06157-11","volume":"86","author":"C Ochsenbauer","year":"2012","unstructured":"Ochsenbauer, C. et al. Generation of transmitted\/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. Journal of virology 86, 2715\u20132728, https:\/\/doi.org\/10.1128\/jvi.06157-11 (2012).","journal-title":"Journal of virology"},{"key":"59596_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.virol.2018.10.016","volume":"526","author":"H Li","year":"2018","unstructured":"Li, H. & Chen, B. K. Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones. Virology 526, 189\u2013202, https:\/\/doi.org\/10.1016\/j.virol.2018.10.016 (2018).","journal-title":"Virology"},{"key":"59596_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1089\/aid.2016.0260","volume":"33","author":"M Ashokkumar","year":"2017","unstructured":"Ashokkumar, M. et al. Molecular Characteristics of the Envelope of Vertically Transmitted HIV-1 Strains from Infants with HIV Infection. AIDS research and human retroviruses 33, 796\u2013806, https:\/\/doi.org\/10.1089\/aid.2016.0260 (2017).","journal-title":"AIDS research and human retroviruses"},{"key":"59596_CR12","doi-asserted-by":"publisher","first-page":"e1003658","DOI":"10.1371\/journal.ppat.1003658","volume":"9","author":"JA Fraietta","year":"2013","unstructured":"Fraietta, J. A. et al. Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection. PLoS pathogens 9, e1003658, https:\/\/doi.org\/10.1371\/journal.ppat.1003658 (2013).","journal-title":"PLoS pathogens"},{"key":"59596_CR13","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1128\/jvi.00451-16","volume":"90","author":"KJ Lavender","year":"2016","unstructured":"Lavender, K. J. et al. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo. Journal of virology 90, 6001\u20136013, https:\/\/doi.org\/10.1128\/jvi.00451-16 (2016).","journal-title":"Journal of virology"},{"key":"59596_CR14","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/nature07831","volume":"458","author":"Q Li","year":"2009","unstructured":"Li, Q. et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458, 1034\u20131038, https:\/\/doi.org\/10.1038\/nature07831 (2009).","journal-title":"Nature"},{"key":"59596_CR15","doi-asserted-by":"publisher","first-page":"e56527","DOI":"10.1371\/journal.pone.0056527","volume":"8","author":"GA Hardy","year":"2013","unstructured":"Hardy, G. A. et al. Interferon-alpha is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. PloS one 8, e56527, https:\/\/doi.org\/10.1371\/journal.pone.0056527 (2013).","journal-title":"PloS one"},{"key":"59596_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/biof.6","volume":"35","author":"V Fensterl","year":"2009","unstructured":"Fensterl, V. & Sen, G. C. Interferons and viral infections. BioFactors (Oxford, England) 35, 14\u201320, https:\/\/doi.org\/10.1002\/biof.6 (2009).","journal-title":"BioFactors (Oxford, England)"},{"key":"59596_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/ceo.12268","volume":"42","author":"XY Wang","year":"2014","unstructured":"Wang, X. Y., Crowston, J. G., White, A. J., Zoellner, H. & Healey, P. R. Interferon-alpha and interferon-gamma modulate Fas-mediated apoptosis in mitomycin-C-resistant human Tenon's fibroblasts. Clinical & experimental ophthalmology 42, 529\u2013538, https:\/\/doi.org\/10.1111\/ceo.12268 (2014).","journal-title":"Clinical & experimental ophthalmology"},{"key":"59596_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrmicro3471","volume":"13","author":"SB Joseph","year":"2015","unstructured":"Joseph, S. B., Swanstrom, R., Kashuba, A. D. & Cohen, M. S. Bottlenecks in HIV-1 transmission: insights from the study of founder viruses. Nature reviews. Microbiology 13, 414\u2013425, https:\/\/doi.org\/10.1038\/nrmicro3471 (2015).","journal-title":"Nature reviews. Microbiology"},{"key":"59596_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.virol.2018.10.016","volume":"526","author":"H Li","year":"2019","unstructured":"Li, H. & Chen, B. K. Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones. Virology 526, 189\u2013202, https:\/\/doi.org\/10.1016\/j.virol.2018.10.016 (2019).","journal-title":"Virology"},{"key":"59596_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-016-0299-0","volume":"13","author":"CS Oberle","year":"2016","unstructured":"Oberle, C. S. et al. Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs. Retrovirology 13, 62, https:\/\/doi.org\/10.1186\/s12977-016-0299-0 (2016).","journal-title":"Retrovirology"},{"key":"59596_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.meegid.2019.02.032","volume":"71","author":"A Abayasingam","year":"2019","unstructured":"Abayasingam, A. et al. Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 71, 36\u201341, https:\/\/doi.org\/10.1016\/j.meegid.2019.02.032 (2019).","journal-title":"Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"key":"59596_CR22","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1126\/science.1093137","volume":"303","author":"CA Derdeyn","year":"2004","unstructured":"Derdeyn, C. A. et al. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science (New York, N.Y.) 303, 2019\u20132022, https:\/\/doi.org\/10.1126\/science.1093137 (2004).","journal-title":"Science (New York, N.Y.)"},{"key":"59596_CR23","doi-asserted-by":"publisher","first-page":"e1002209","DOI":"10.1371\/journal.ppat.1002209","volume":"7","author":"S Gnanakaran","year":"2011","unstructured":"Gnanakaran, S. et al. Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. PLoS pathogens 7, e1002209, https:\/\/doi.org\/10.1371\/journal.ppat.1002209 (2011).","journal-title":"PLoS pathogens"},{"key":"59596_CR24","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1073\/pnas.0802203105","volume":"105","author":"BF Keele","year":"2008","unstructured":"Keele, B. F. et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America 105, 7552\u20137557, https:\/\/doi.org\/10.1073\/pnas.0802203105 (2008).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"59596_CR25","doi-asserted-by":"publisher","first-page":"e1005154","DOI":"10.1371\/journal.ppat.1005154","volume":"11","author":"MJ Deymier","year":"2015","unstructured":"Deymier, M. J. et al. Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-alpha Resistance. PLoS pathogens 11, e1005154, https:\/\/doi.org\/10.1371\/journal.ppat.1005154 (2015).","journal-title":"PLoS pathogens"},{"key":"59596_CR26","doi-asserted-by":"publisher","first-page":"E590","DOI":"10.1073\/pnas.1620144114","volume":"114","author":"SS Iyer","year":"2017","unstructured":"Iyer, S. S. et al. Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness. Proceedings of the National Academy of Sciences of the United States of America 114, E590\u2013e599, https:\/\/doi.org\/10.1073\/pnas.1620144114 (2017).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"59596_CR27","doi-asserted-by":"publisher","first-page":"e1006944","DOI":"10.1371\/journal.ppat.1006944","volume":"14","author":"A Kumar","year":"2018","unstructured":"Kumar, A. et al. Infant transmitted\/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma. PLoS pathogens 14, e1006944, https:\/\/doi.org\/10.1371\/journal.ppat.1006944 (2018).","journal-title":"PLoS pathogens"},{"key":"59596_CR28","doi-asserted-by":"publisher","unstructured":"Ashokkumar, M., Aralaguppe, S. G., Tripathy, S. P., Hanna, L. E. & Neogi, U. Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses. Journal of virology 92, https:\/\/doi.org\/10.1128\/jvi.00063-18 (2018).","DOI":"10.1128\/jvi.00063-18"},{"key":"59596_CR29","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1089\/aid.2016.0093","volume":"32","author":"M Ashokkumar","year":"2016","unstructured":"Ashokkumar, M., Tripathy, S. P. & Hanna, L. E. Variability in V1V2 and PNGs in Pediatric HIV-1 Viral Variants Transmitted Through Vertical Route. AIDS research and human retroviruses 32, 942\u2013943, https:\/\/doi.org\/10.1089\/aid.2016.0093 (2016).","journal-title":"AIDS research and human retroviruses"},{"key":"59596_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep38130","volume":"6","author":"H Song","year":"2016","unstructured":"Song, H. et al. Transmission of Multiple HIV-1 Subtype C Transmitted\/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences. Scientific reports 6, 38130, https:\/\/doi.org\/10.1038\/srep38130 (2016).","journal-title":"Scientific reports"},{"key":"59596_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1084\/jem.20041196","volume":"200","author":"S Mehandru","year":"2004","unstructured":"Mehandru, S. et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. The Journal of experimental medicine 200, 761\u2013770, https:\/\/doi.org\/10.1084\/jem.20041196 (2004).","journal-title":"The Journal of experimental medicine"},{"key":"59596_CR32","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1128\/jvi.02964-12","volume":"87","author":"ZF Parker","year":"2013","unstructured":"Parker, Z. F. et al. Transmitted\/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. Journal of virology 87, 2401\u20132411, https:\/\/doi.org\/10.1128\/jvi.02964-12 (2013).","journal-title":"Journal of virology"},{"key":"59596_CR33","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1128\/aac.49.11.4721-4732.2005","volume":"49","author":"P Dorr","year":"2005","unstructured":"Dorr, P. et al. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrobial agents and chemotherapy 49, 4721\u20134732, https:\/\/doi.org\/10.1128\/aac.49.11.4721-4732.2005 (2005).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"59596_CR34","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1128\/JVI.00106-11","volume":"85","author":"M Roche","year":"2011","unstructured":"Roche, M. et al. HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropism. Journal of virology 85, 4330\u20134342, https:\/\/doi.org\/10.1128\/JVI.00106-11 (2011).","journal-title":"Journal of virology"},{"key":"59596_CR35","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1128\/jvi.00780-09","volume":"83","author":"R Nedellec","year":"2009","unstructured":"Nedellec, R. et al. Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype. Journal of virology 83, 8353\u20138363, https:\/\/doi.org\/10.1128\/jvi.00780-09 (2009).","journal-title":"Journal of virology"},{"key":"59596_CR36","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.1128\/jvi.00296-09","volume":"83","author":"J Isaacman-Beck","year":"2009","unstructured":"Isaacman-Beck, J. et al. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. Journal of virology 83, 8208\u20138220, https:\/\/doi.org\/10.1128\/jvi.00296-09 (2009).","journal-title":"Journal of virology"},{"key":"59596_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/v10080413","volume":"10","author":"J Yu","year":"2018","unstructured":"Yu, J. & Liu, S.-L. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage. Viruses 10, 413, https:\/\/doi.org\/10.3390\/v10080413 (2018).","journal-title":"Viruses"},{"key":"59596_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.chom.2016.08.006","volume":"20","author":"TL Foster","year":"2016","unstructured":"Foster, T. L. et al. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction. Cell host & microbe 20, 429\u2013442, https:\/\/doi.org\/10.1016\/j.chom.2016.08.006 (2016).","journal-title":"Cell host & microbe"},{"key":"59596_CR39","doi-asserted-by":"publisher","first-page":"e1002721","DOI":"10.1371\/journal.ppat.1002721","volume":"8","author":"KJ Bar","year":"2012","unstructured":"Bar, K. J. et al. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS pathogens 8, e1002721, https:\/\/doi.org\/10.1371\/journal.ppat.1002721 (2012).","journal-title":"PLoS pathogens"},{"key":"59596_CR40","doi-asserted-by":"publisher","first-page":"eaat0843","DOI":"10.1126\/sciadv.aat0843","volume":"4","author":"R El-Diwany","year":"2018","unstructured":"El-Diwany, R. et al. CMPK2 and BCL-G are associated with type 1 interferon-induced HIV restriction in humans. Science advances 4, eaat0843, https:\/\/doi.org\/10.1126\/sciadv.aat0843 (2018).","journal-title":"Science advances"},{"key":"59596_CR41","doi-asserted-by":"crossref","first-page":"158.112","DOI":"10.4049\/jimmunol.198.Supp.158.12","volume":"198","author":"M Soliman","year":"2017","unstructured":"Soliman, M., El-Diwany, R., Wheelan, S., Thomas, D. L. & Balagopal, A. Identification of CMPK2 as an Interferon Stimulated Gene that Restricts HIV Infection. The Journal of Immunology 198, 158.112 (2017).","journal-title":"The Journal of Immunology"},{"key":"59596_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrmicro3449","volume":"13","author":"T Doyle","year":"2015","unstructured":"Doyle, T., Goujon, C. & Malim, M. H. HIV-1 and interferons: who&#39;s interfering with whom? Nature Reviews Microbiology 13, 403, https:\/\/doi.org\/10.1038\/nrmicro3449 (2015).","journal-title":"Nature Reviews Microbiology"},{"key":"59596_CR43","doi-asserted-by":"publisher","first-page":"S667","DOI":"10.1093\/infdis\/jiu369","volume":"210","author":"M Sagar","year":"2014","unstructured":"Sagar, M. Origin of the Transmitted Virus in HIV Infection: Infected Cells Versus Cell-Free Virus. The Journal of infectious diseases 210, S667\u2013S673, https:\/\/doi.org\/10.1093\/infdis\/jiu369 (2014).","journal-title":"The Journal of infectious diseases"},{"key":"59596_CR44","doi-asserted-by":"publisher","first-page":"e00934","DOI":"10.1128\/mBio.00934-16","volume":"7","author":"D Kmiec","year":"2016","unstructured":"Kmiec, D. et al. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance. mBio 7, e00934\u201300916, https:\/\/doi.org\/10.1128\/mBio.00934-16 (2016).","journal-title":"mBio"},{"key":"59596_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.virol.2010.12.029","volume":"411","author":"O Latinovic","year":"2011","unstructured":"Latinovic, O. et al. CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells. Virology 411, 32\u201340, https:\/\/doi.org\/10.1016\/j.virol.2010.12.029 (2011).","journal-title":"Virology"},{"key":"59596_CR46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.15698\/mic2016.09.529","volume":"3","author":"JC Becerra","year":"2016","unstructured":"Becerra, J. C., Bildstein, L. S. & Gach, J. S. Recent Insights into the HIV\/AIDS Pandemic. Microbial cell (Graz, Austria) 3, 451\u2013475, https:\/\/doi.org\/10.15698\/mic2016.09.529 (2016).","journal-title":"Microbial cell (Graz, Austria)"},{"key":"59596_CR47","doi-asserted-by":"publisher","first-page":"12582","DOI":"10.1128\/jvi.00381-07","volume":"81","author":"P Chen","year":"2007","unstructured":"Chen, P., Hubner, W., Spinelli, M. A. & Chen, B. K. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. Journal of virology 81, 12582\u201312595, https:\/\/doi.org\/10.1128\/jvi.00381-07 (2007).","journal-title":"Journal of virology"},{"key":"59596_CR48","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.chom.2014.10.002","volume":"16","author":"SF Kluge","year":"2014","unstructured":"Kluge, S. F. et al. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell host & microbe 16, 639\u2013650, https:\/\/doi.org\/10.1016\/j.chom.2014.10.002 (2014).","journal-title":"Cell host & microbe"}],"updated-by":[{"DOI":"10.1038\/s41598-020-68818-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59596-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59596-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59596-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:21:19Z","timestamp":1695774079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59596-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59596"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59596-x","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-020-68818-1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,17]]},"assertion":[{"value":"10 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2747"}}